Faricimab for treating wet age-related macular degeneration

Equality Impact Assessment (Guidance development) (PDF 142 KB)

Register of interests (PDF 272 KB)

Final draft guidance

Final appraisal document (PDF 155 KB)

Committee papers (PDF 2.12 MB)

Final scope (PDF 191 KB)

Final stakeholder list (PDF 196 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 320 KB)

Equality impact assessment (Scoping) (PDF 122 KB)

Draft scope post referral (PDF 206 KB)

Draft matrix post referral (PDF 193 KB)